Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease'

European Journal of Heart Failure(2022)

Cited 0|Views2
No score
Abstract
European Journal of Heart FailureEarly View Letter to the Editor Reply to ‘Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease’ Trond J. Cooper, Corresponding Author Trond J. Cooper trond.cooper@gmail.com Stavanger University Hospital, Stavanger, Norway Corresponding author. Email: trond.cooper@gmail.comSearch for more papers by this authorPierpaolo Pellicori, Pierpaolo Pellicori Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UKSearch for more papers by this authorAnastasia Ushakova, Anastasia Ushakova Stavanger University Hospital, Stavanger, NorwaySearch for more papers by this authorKenneth Dickstein, Kenneth Dickstein Stavanger University Hospital, Stavanger, Norway University of Bergen, Bergen, NorwaySearch for more papers by this author Trond J. Cooper, Corresponding Author Trond J. Cooper trond.cooper@gmail.com Stavanger University Hospital, Stavanger, Norway Corresponding author. Email: trond.cooper@gmail.comSearch for more papers by this authorPierpaolo Pellicori, Pierpaolo Pellicori Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit, University of Glasgow, University Avenue, Glasgow, UKSearch for more papers by this authorAnastasia Ushakova, Anastasia Ushakova Stavanger University Hospital, Stavanger, NorwaySearch for more papers by this authorKenneth Dickstein, Kenneth Dickstein Stavanger University Hospital, Stavanger, Norway University of Bergen, Bergen, NorwaySearch for more papers by this author First published: 17 September 2022 https://doi.org/10.1002/ejhf.2690Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation
More
Translated text
Key words
pulmonary hypertension,heart disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined